Correction to: Scientific Reports https://doi.org/10.1038/s41598-021-90748-9, published online 5 March 2021
The original version of this Article contained errors.
As a result of an error during figure assembly, the Article contained a duplication of Fig. 1C 4F2hc in Fig. 1D 4F2hc. Since the original data for Fig. 1D was not available the Authors repeated the experiments, and Fig. 1D is now corrected with this new data, and the original images in SI file are also now updated. Additionally, Fig. 1C 4F2hc is duplicated in Fig. 4E 4F2hc. This duplication is intentional, as it represents the same experiment, but should have been disclosed.
Consequently, the legend of Fig. 1 was corrected as follows:
“4F2hc signalling pathway. Cell cycle analysis was performed with si4F2hc (si4F2hc-1 and si4F2hc-2) and compared with a control group (A to D). After 72 h or 96 h, si4F2hc (si4F2hc-1 and si4F2hc-2) downregulation of SKP2, phosphorylation of AKT and MAPK, and increased expression of p21 and p27 (E). Data represent three independent experiments with similar results.”
now reads:
“4F2hc signalling pathway. Cell cycle analysis was performed with si4F2hc (si4F2hc-1 and si4F2hc-2) and compared with a control group (A to D). After 72 h or 96 h, si4F2hc (si4F2hc-1 and si4F2hc-2) downregulation of SKP2, phosphorylation of AKT and MAPK, and increased expression of p21 and p27 (E). Data represent three independent experiments with similar results. Data for 4F2hc comes from the same experiment as depicted in Fig 1C.”
The original Fig. 1 and accompanying legend appear below.
4F2hc signalling pathway. Cell cycle analysis was performed with si4F2hc (si4F2hc-1 and si4F2hc-2) and compared with a control group (A–D). After 72 h or 96 h, si4F2hc (si4F2hc-1 and si4F2hc-2) downregulation of SKP2, phosphorylation of AKT and MAPK, and increased expression of p21 and p27 (E). Data represent three independent experiments with similar results. Data for 4F2hc comes from the same experiment as depicted in (C).
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Maimaiti, M., Sakamoto, S., Sugiura, M. et al. Author Correction: The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2. Sci Rep 15, 6411 (2025). https://doi.org/10.1038/s41598-025-89150-6
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-89150-6
